A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/551 (2006.01) A61K 31/4535 (2006.01) A61K 31/473 (2006.01) A61K 31/55 (2006.01) A61K 31/662 (2006.01) A61K 31/7068 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2532347
The present invention relates to a method of treatment or prevention of acute and/or chronic neurological disorders, to a pharmaceutical composition comprising an inhibitor of acetylcholinesterase (AChE inhibitor) and a metabotropic Glutamate receptor 2 antagonist (mGluR2 antagonist), to the use of an AChE inhibitor and a mGluR2 antagonist in the preparation of a medicament, and. to kits comprising an AChE inhibitor and a mGluR2 antagonist.
La présente invention concerne une technique de traitement ou de prévention de troubles neurologiques aigus et/ou chroniques, une composition pharmaceutique comprenant un inhibiteur d'acétylcholinesterase (inhibiteur AchE) et un antagoniste du récepteur 2 de glutamate métabotropique (antagoniste mGluR2), l'utilisation d'un inhibiteur AChE et d'un antagoniste mGluR2 dans la préparation d'un médicament et, des kits comprenant un inhibiteur AChE et un antagoniste mGluR2.
Ballard Theresa Maria
Gatti Mcarthur Silvia
Goetschi Erwin
Wichmann Juergen
Woltering Thomas Johannes
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Combination of mglur2 antagonist and ache inhibitor for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of mglur2 antagonist and ache inhibitor for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of mglur2 antagonist and ache inhibitor for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1888544